
Kolosis BIO Announces Strong 2022 Results
Kolosis BIO, LLC (Kolosis), a pure-play orthobiologics company and an exclusive partner to MTF Biologics, announced today its 2021 results and 2022 expectations.
It’s Time to Upgrade your Orthobiologics Options
Kore Fiber approved in over 40 health systems
Kolosis bone grafts on shelf in more than 270 hospitals
In past 12 months, Kore and Prime HD utilized
in over 6000 fusion procedures
Kolosis grafts on hospital shelves in Canada
and 46 US states
International distribution footprint with over 125 independent distributors
Why Choose MTF Grafts?
Kolosis BIO, LLC (Kolosis), a pure-play orthobiologics company and an exclusive partner to MTF Biologics, announced today its 2021 results and 2022 expectations.
Kolosis BIO, a privately-held pure-play orthobiologics company, announced today the appointment of Charles Crockett as Area Vice President of Sales, East.
Kolosis BIO, a privately-held pure-play orthobiologics company, announced today the appointment of Michelle Soleimani-Mafi as its Director of Operations.